COVID-19 vaccines: Pfizer-BioNTech shot likely to foil mutant, new study shows
COVID-19 vaccines: Pfizer-BioNTech shot likely to foil mutant, new study shows Study on South Africa strain suggests some re-infection threat Naomi Kresge and Janice Kew, Bloomberg Jan. 20, 2021 FacebookTwitterEmail Pfizer Inc. and BioNTech SE built the case that their Covid-19 vaccine will protect against the new variant of the coronavirus that emerged in the U.K. with results of another lab trial. Like previous work out of the University of Texas Medical Branch, the results published on Wednesday showed that antibodies in the blood of people who had been vaccinated were able to neutralize ...
Source: lmtonline.com